• Global Hemp Group Inc. (GHG) announces a $1.32 million private placement
  • The non-brokered private placement will consist of up to 60 million units
  • The company is also exploring a securitized token initiative to fund the development of its Green Community/Hemp Agro-Industrial Zone project in Hayden, Colorado
  • The net proceeds from these funding initiatives will be used for the continuing development of the project, expansion of the Mexican project initiatives, and general working capital purposes
  • Global Hemp Group Inc. (GHG) is unchanged trading at $0.025 per share as of 3:23 p.m. EST

Global Hemp Group Inc. (GHG) has announced a $1.3M private placement and is exploring a securitized token initiative.

The non-brokered private placement will consist of up to 60 million units at a price of $0.02 per unit.

Each unit is comprised of one common share and one share purchase warrant.

Each warrant will entitle the holder to acquire one additional share at a price of $0.05 per common share until September 8, 2023.

The warrants will be listed for trading under the symbol GHG.WT.

Global Hemp is also exploring a parallel securitized token initiative to fund the development of its Green Community/Hemp Agro-Industrial Zone project in Hayden, Colorado.

The net proceeds from these funding initiatives will be used for the continuing development of the project, expansion of the Mexican project initiatives in research and development, and general working capital purposes.

Global Hemp is collaborating with Western Sierra Resource Corporation on the project for beneficial use of existing water infrastructure to cultivate hemp, an on-site manufacturing facility for renewable construction products, and to build affordable carbon neutral/negative housing.

Global Hemp Group Inc. (GHG) is unchanged trading at $0.025 per share as of 3:23 p.m. EST.

More From The Market Online

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

The Market Online’s Weekly Cannabis Report – May 10, 2024

A leading North American cannabis and consumer packaged goods company will acquire key players in its U.S. expansion strategy.